Permanently Discontinued

APO AMPI CAPSULES 500MG

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO AMPI CAPSULES 500MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO AMPI CAPSULES 500MG has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO AMPI CAPSULES 500MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength500MG

Last updated2017-10-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PRO AMPI 500 CAP 500MG

PRO DOC LIMITEE

500MG · DIN 00628360

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

AMPICIN INJ 500MG

BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB

500MG · DIN 00004057

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

NOVO-AMPICILLIN PWS 500MG/5ML

NOVOPHARM LIMITED

500MG · DIN 00231207

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PENBRITIN PWS 250MG/5ML

AYERST LABORATORIES

250MG · DIN 00002429

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

NOVO-AMPICILLIN SUS 125MG/5ML

NOVOPHARM LIMITED

125MG · DIN 00021121

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PENGLOBE TAB 800 MG

ASTRAZENECA CANADA INC

800MG · DIN 00627135

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00603295

Strength

500MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

AMPICILLIN

See all AMPICILLIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244